Author:
Zhang Jianjun,Chen Xinlian,Shi Gang,Xie Xiaoyan,Liu Hongqian,Zhang Xuemei,Lai Yi,Zuo Yan,Chen Zhong,Liu Shanling,Wang He
Abstract
Abstract
Background
Intraperitoneal (i.p.) models that accurately mimic the feature behavior of human ovarian cancer are required to investigate the pathology and therapeutics of the disease. However, established i.p. models which are well-characterized and reliable are few. The purposes of this study are to establish a representative mice i.p. model of the disease and to analyze the consequent pathology.
Methods
Fresh tumor cells fiom the ascites of patient were injected into female NOD/SCID mice intraperitoneally. Histology, Cytogenetic, immunohistochemistry,tumor markers of CA125,AFP, CA-199 and CEA were used to analyze the model.
Results
The mice developed marked abdominal distention within 6 months after inoculated with tumor cells from a patient with epithelial ovarian carcinoma. The mice developed clinically evident intraperitoneal tumors and massive ascites containing numerous tumor cells in clumps. CA125 level in our model was high in both serum and ascites supernatants, while levels of other tumor markers, such as AFP, CA-199 and CEA, were normal. Cytogenetic analysis and immunohistochemical staining confirmed its characteristics resembling human epithelial ovarian tumor.
Conclusions
The model described in this paper accurately mimics the features of ovarian tumor, which may be useful for evaluation of new therapeutics.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Oncology
Reference28 articles.
1. Jemal A, Siegel R, Xu JQ, Ward E: Cancer statistics, 2010. CA-Cancer J Clin 2010, 60: 277–300. 10.3322/caac.20073
2. Deraco M, Baratti D, Laterza B, Balestra MR, Mingrone E, Macrì A, Virzì S, Puccio F, Ravenda PS, Kusamura S: Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer. Eur J Surg Oncol 2011, 37: 4–9. 10.1016/j.ejso.2010.11.004
3. Shaw TJ, Senterman MK, Dawson K, Crane CA, Vanderhyden BC: Characterization of Intraperitoneal, Orthotopic, and Metastatic Xenograft Models of Human Ovarian Cancer. Mol Ther 2004, 10: 1032–1042. 10.1016/j.ymthe.2004.08.013
4. Elkas JC, Baldwin RL, Pegram M, Tseng Y, Slamon D, Karlan BY: A human ovarian carcinoma murine xenograft model useful for preclinical trials. Gynecol Oncol 2002, 87: 200–206. 10.1006/gyno.2002.6819
5. Verschraegen CF, Hu W, Du Y, Mendoza J, Early J, Deavers M, Freedman RS, Bast RC Jr, Kudelka AP, Kavanagh JJ, Giovanella BC: Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers. Clin Cancer Res 2003, 9: 845–852.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献